PRESS RELEASE

from SARTORIUS STED BIO (EPA:DIM)

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech

Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech

02-Jul-2024 / 11:25 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


 

 

Aubagne, July 2nd, 2024

 

Half-year liquidity contract statement for Sartorius Stedim Biotech

 

Under the liquidity contract entered into between Sartorius Stedim Biotech and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th 2024:
 

  • 46,292 shares
  • € 2,521,189.91
  • Number of executions on buy side on semester: 6,493
  • Number of executions on sell side on semester: 5,322
  • Traded volume on buy side on semester: 305,402 shares for € 69,412,550.00
  • Traded volume on sell side on semester: 273,281 shares for € 63,664,027.43

 

As a reminder :
 

The following resources appeared on the last half year statement on 31 December 2023 on the liquidity account:

 

  • 14,171 shares
  • € 8,132,662.14
  • Number of executions on buy side on semester: 5,238
  • Number of executions on sell side on semester: 4,912
  • Traded volume on buy side on semester: 230,377 shares for € 50,832,014.40
  • Traded volume on sell side on semester: 239,123 shares for € 54,101,099.12

 

The following resources appeared on the liquidity account when the activity started:

 

  • 0 shares
  • € 10,000,000.00

 

 

The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.

A profile of Sartorius Stedim Biotech

Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a provider of innovative solutions, the company based in Aubagne, France, helps its customers to manufacture biotech medications, such as cell and gene therapies, safely, rapidly, and economically. The shares of Sartorius Stedim Biotech S.A. are quoted on the Euronext Paris. The company has a strong global reach with manufacturing and R&D sites as well as sales entities in Europe, North America, and Asia. Sartorius Stedim Biotech regularly expands its portfolio through acquisitions of complementary technologies. In 2023, the company generated sales revenue of around 2.8 billion euros. Currently, more than 10,600 employees are working for customers around the globe.

 

Contact

Petra Müller

Head of Investor Relations

+49 (0)551.308.6035

Petra.mueller2@sartorius.com

 

Sartorius Stedim Biotech S.A.

Z.I. Les Paluds

Avenue de Jouques, CS 91051

13781 Aubagne Cedex, France

Phone: +33.(0)4.42.84.56.00

Fax: +33.(0)4.42.84.56.19

www.sartorius.com

 

 

 

 

Buy side

Sell side

 

Number of executions

Number of shares

Traded volume in EUR

Number of executions

Number of shares

Traded volume in EUR

Total

6,493

305,402

69,412,550.00

5,322

273,281

63,664,027.43

01/02/2024

16

1,000

244,350.00

107

4,495

1,109,725.60

01/03/2024

82

3,428

839,277.24

28

1,600

393,104.00

01/04/2024

91

3,592

864,342.96

41

1,662

404,397.84

01/05/2024

103

3,499

818,731.01

54

2,800

660,492.00

01/08/2024

92

3,350

786,881.50

47

2,500

590,150.00

01/09/2024

33

1,700

403,546.00

36

2,300

550,390.00

01/10/2024

85

3,800

912,152.00

44

1,901

460,346.16

01/11/2024

74

3,350

793,816.00

50

2,601

620,234.46

01/12/2024

65

3,500

821,065.00

59

2,600

616,070.00

01/15/2024

54

1,900

440,952.00

31

1,611

374,879.70

01/16/2024

165

4,500

1,004,760.00

32

1,900

427,994.00

01/17/2024

62

2,700

600,723.00

41

1,400

313,026.00

01/18/2024

54

2,400

533,784.00

37

1,800

403,704.00

01/19/2024

35

1,991

433,878.72

47

2,600

570,908.00

01/22/2024

41

1,700

378,658.00

63

2,500

559,900.00

01/23/2024

55

2,540

565,683.40

46

2,225

497,376.50

01/24/2024

71

3,300

740,487.00

72

3,176

716,473.84

01/25/2024

48

2,470

551,872.10

86

4,009

903,548.42

01/26/2024

54

2,605

614,884.20

125

6,725

1,618,976.50

01/29/2024

65

3,303

788,591.25

47

2,826

680,755.14

01/30/2024

108

5,073

1,186,879.08

83

4,604

1,103,716.92

01/31/2024

-

-

-

84

4,599

1,135,171.17

02/01/2024

58

2,675

663,186.00

29

1,423

354,711.21

02/02/2024

85

4,200

1,036,182.00

55

1,777

444,392.16

02/05/2024

43

1,700

411,400.00

55

3,002

732,217.82

02/06/2024

44

2,140

525,669.60

50

2,500

619,550.00

02/07/2024

91

4,300

See all SARTORIUS STED BIO news